July 31, 2018 Clinical Research/Diagn. M&A, Partnerships

QIAGEN creates collaboration with Japan’s largest clinical laboratory testing company, SRL, to accelerate launch of companion diagnostics

Hilden, Germany, and Tokyo, Japan, August 1, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a collaboration with SRL, Inc., the largest clinical testing laboratory company in Japan, to prepare for introduction of new companion diagnostics simultaneous with new drug approvals. The non-exclusive master collaboration agreement for clinical laboratory research services... Read more

July 31, 2018 Clinical Research/Diagn. PR/Corporate

QIAGEN’s careHPV™ Test wins WHO prequalification status for cervical cancer screening

Hilden, Germany, and Germantown, Maryland, August 1, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its careHPV™ Test, one of the only molecular diagnostics for high-risk human papillomavirus (HPV) designed to screen women in low-resource settings, has been added to the World Health Organization (WHO) list of prequalified in vitro diagnostics... Read more

July 31, 2018 Atomic Spectroscopy Clinical Research/Diagn. PR/Corporate

Thermo Fisher Scientific Showcases Innovations for Research and Clinical Labs at AACC 2018

Thermo Fisher Scientific Showcases Innovations for Research and Clinical Labs at AACC 2018 CHICAGO, July 31, 2018 /PRNewswire/ — AACC — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is showcasing its latest innovations for clinical and translational research during the 2018 American Association of Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo (booth 3831), being... Read more

July 31, 2018 Chromatography Clinical Research/Diagn. Lab Top-10 Mass Spectrometry Product Launch

New Triple Quadrupole Mass Spectrometer offers Robust and Fast Analysis with LC-MS/MS for Clinical Research Laboratories

New Triple Quadrupole Mass Spectrometer offers Robust and Fast Analysis with LC-MS/MS for Clinical Research Laboratories Robust Thermo Scientific TSQ Fortis Triple Quadrupole mass spectrometer designed for productivity across all levels of users CHICAGO – AACC – (July 31, 2018) – Scientists in clinical research laboratories facing challenges in developing robust, reproducible, and reliable methods... Read more

July 31, 2018 Clinical Research/Diagn. Lab Top-10 PR/Corporate

Thermo Fisher Scientific Showcases Innovations for Research and Clinical Labs at AACC 2018

CHICAGO, July 31, 2018 /PRNewswire/ — AACC — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is showcasing its latest innovations for clinical and translational research during the 2018 American Association of Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo (booth 3831), being held July 29 – August 2 at McCormick Place... Read more

July 31, 2018 Clinical Research/Diagn. Lab Equipment Lab Top-10 Product Launch

New Compact Refrigerators Designed for Secure and Sustainable Clinical Storage

The Thermo Scientific TSG Series of refrigerators maintain optimal cold storage conditions with minimal energy consumption and noise output CHICAGO, July 31, 2018 /PRNewswire/ — AACC — A new series of compact refrigerators has been specifically developed to address the need of clinical laboratories and patient care facilities for cold storage equipment that enable secure and... Read more

July 31, 2018 Clinical Research/Diagn.

GE Healthcare and Lantheus Announce Start of a Phase 3 Clinical Trial of Flurpiridaz, an Investigational Agent Being Evaluated for the Detection of Coronary Artery Disease

Boston and North Billerica, MA, USA – July 31, 2018 – GE Healthcare and Lantheus Holdings, Inc. (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. (collectively “Lantheus”), have started a second Phase 3 clinical trial of Flurpiridaz 18F (called the AURORA study), an investigational agent being evaluated for the detection of coronary artery disease... Read more

July 31, 2018 Clinical Research/Diagn. Lab Top-10 Liq. Handling & Robotics PR/Corporate Product Launch

New Phadia 200 Advances In-vitro Diagnostics in Europe for Allergy and Autoimmune Conditions

CHICAGO – AACC – (July 31, 2018) – A new benchtop instrument from Thermo Fisher Scientific, the Phadia 200, enables new levels of flexibility and automation for laboratory testing facilities to aid in the diagnosis of allergy and autoimmunity conditions. The Phadia 200 is CE-marked, and the first installations are underway at select European sites.... Read more

July 31, 2018 Cell Analysis Tools Clinical Research/Diagn. Lab Top-10 PR/Corporate Product Launch

New Compounds Now Available for Antimicrobial Susceptibility Testing: Delafloxacin and Meropenem/Vaborbactam

FDA-cleared microbroth dilution plates provide true minimum inhibitory concentration (MIC) results, facilitating more targeted patient therapy CHICAGO – AACC – (July 31, 2018) – The antimicrobial delafloxacin, and the combination of meropenem and vaborbactam are now available on FDA-cleared microbroth dilution susceptibility plates. Delafloxacin is available for testing select fastidious and non-fastidious Gram positive and... Read more